A large, multi-layered analysis combining epidemiological, clinical, and molecular data provides strong, convergent evidence that Barrett’s oesophagus is the precursor lesion for oesophageal adenocarcinoma (EAC), helping resolve longstanding uncertainty around disease origin and informing future screening strategies.
EAC incidence has risen markedly in recent decades and remains associated with poor outcomes, largely due to late diagnosis. Barrett’s oesophagus—defined by intestinal metaplasia of the distal oesophagus—has long been considered the main precursor, but has only been identified in around half of EAC cases, raising questions about alternative pathways.
CLINICAL SUMMARY
What was examined
Integrated epidemiological, clinical, and genomic analyses to determine whether Barrett’s oesophagus is the precursor to oesophageal adenocarcinoma.
Key findings
- Findings support Barrett’s oesophagus as the likely universal precursor to oesophageal adenocarcinoma.
- Genomic and molecular data demonstrate a shared evolutionary pathway between Barrett’s tissue and invasive cancer.
- Apparent absence of Barrett’s in some cases likely reflects tumour overgrowth or limitations in detection and sampling.g
Clinical implications
- Reinforces Barrett’s oesophagus as the central target for screening and surveillance strategies
- Supports improved detection approaches and biomarker-driven risk stratification
- Highlights a window for early intervention,n given the prolonged progression from precursor to cancer
In this study, investigators integrated large epidemiological and genomic datasets with clinical observations to address that gap. Their findings support Barrett’s oesophagus as the likely universal precursor to EAC, including in cases where it is not clinically detected.
Molecular analyses suggest that the apparent absence of Barrett’s oesophagus in some patients likely reflects tumour overgrowth or limitations in detection and sampling, rather than a distinct biological pathway. Genomic comparisons further demonstrated shared mutational patterns between Barrett’s tissue and EAC, reinforcing a direct evolutionary relationship.
The study also highlights that progression from Barrett’s oesophagus to invasive cancer is a prolonged, multistep process, suggesting a meaningful window for early detection and intervention.
Featured Event
From a clinical perspective, these findings strengthen the rationale for screening and surveillance strategies focused on Barrett’s oesophagus, particularly in at-risk populations. They also support ongoing efforts to refine risk stratification using molecular biomarkers to identify individuals most likely to progress.
The authors suggest that improving the detection of Barrett’s oesophagus should be a priority for efforts to reduce EAC mortality.
Paper: Zamani, S.A., Wu, L., Black, E.L. et al. Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinoma. Nat Med (2026). Access online here.
